COVID-19 Genomic Surveillance in Bangui (Central African Republic) Reveals a Landscape of Circulating Variants Linked to Validated Antiviral Targets of SARS-CoV-2 Proteome

• Published in: Viruses Vol. 15; no. 12; p. 2309
• Main Authors: Vickos, Ulrich, Camasta, Marianna, Grandi, Nicole, Scognamiglio, Sante, Schindler, Tobias, Belizaire, Marie Roseline Darnycka, Lango-Yaya, Ernest, Koyaweda, Giscard Wilfried, Senzongo, Oscar, Pounguinza, Simon, Estimé, Kaleb Kandou Jephté Francis, N'yetobouko, Stephanie, Gadia, Christelle Luce Bobossi, Feiganazoui, Dominos-Alfred, Le Faou, Alain, Orsini, Massimiliano, Perno, Carlo Federico, Zinzula, Luca, Rafaï, Clotaire Donatien
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 24-11-2023; MDPI
• Subjects: Antigens; Antiviral Agents; Asymptomatic; Causes of; Central African Republic; Central African Republic - epidemiology; Coronaviruses; COVID-19; COVID-19 - epidemiology; COVID-19 vaccines; Delta variant; Disease transmission; Displaced persons; Epidemics; Expatriates; Genomes; Genomics; Humans; Life Sciences; Microbiology and Parasitology; Mutation; Pandemics; Phylogenetics; Phylogeny; Proteins; Proteome; Proteomes; SARS-CoV-2; SARS-CoV-2 - genetics; screening; Severe acute respiratory syndrome coronavirus 2; Statistics; Virology; Central African Republic; United States > US; Germany; Africa; COVID-19; SARS-CoV-2; screening; Delta variant; Central African Republic; severe acute respiratory syndrome coronavirus 2
• ISSN: 1999-4915; 1999-4915
• DOI: 10.3390/v15122309

Since its outbreak, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) spread rapidly, causing the Coronavirus Disease 19 (COVID-19) pandemic. Even with the vaccines' administration, the virus continued to circulate due to inequal access to prevention and therapeutic measures in African countries. Information about COVID-19 in Africa has been limited and contradictory, and thus regional studies are important. On this premise, we conducted a genomic surveillance study about COVID-19 lineages circulating in Bangui, Central African Republic (CAR). We collected 2687 nasopharyngeal samples at four checkpoints in Bangui from 2 to 22 July 2021. Fifty-three samples tested positive for SARS-CoV-2, and viral genomes were sequenced to look for the presence of different viral strains. We performed phylogenetic analysis and described the lineage landscape of SARS-CoV-2 circulating in the CAR along 15 months of pandemics and in Africa during the study period, finding the Delta variant as the predominant Variant of Concern (VoC). The deduced aminoacidic sequences of structural and non-structural genes were determined and compared to reference and reported isolates from Africa. Despite the limited number of positive samples obtained, this study provides valuable information about COVID-19 evolution at the regional level and allows for a better understanding of SARS-CoV-2 circulation in the CAR.